Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Effect of Intravitreal Faricimab in Patients With Refractory Macular Edema and Refractory Age Related Macular Degeneration

NCT07093385 is registered in ClinicalTrials.gov with University of Baghdad as lead sponsor.

NCT NCT07093385
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07093385 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Effect of Intravitreal Faricimab in Patients With Refractory Macular Edema and Refractory Age Related Macular Degeneration
Lead sponsor
University of Baghdad
Phase
Phase 2
Overall status
Completed
Start date
September 10, 2024
Completion date
July 1, 2025
Enrollment
43 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

age-related macular degeneration